These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28387280)

  • 1. Radiographic evidence of treatment with bisphosphonates.
    Thayer ML
    Br Dent J; 2017 Apr; 222(7):507-510. PubMed ID: 28387280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between osteoporosis and oral bone loss.
    Jeffcoat M
    J Periodontol; 2005 Nov; 76(11 Suppl):2125-32. PubMed ID: 16277585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bisphosphonate].
    Hagino H
    Nihon Rinsho; 2011 Jul; 69(7):1253-7. PubMed ID: 21774367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.
    Rossini M; Orsolini G; Viapiana O; Adami S; Gatti D
    Endocrine; 2015 Aug; 49(3):620-7. PubMed ID: 25649760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates. A cornerstone of osteoporosis treatment.
    Mayo Clin Womens Healthsource; 2007 May; 11(5):1-2. PubMed ID: 17476171
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates.
    Puhaindran ME; Farooki A; Steensma MR; Hameed M; Healey JH; Boland PJ
    J Bone Joint Surg Am; 2011 Jul; 93(13):1235-42. PubMed ID: 21776577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of SAPHO syndrome with diffuse sclerosing osteomyelitis of the mandible treated successfully with prednisolone and bisphosphonate.
    Hatano H; Shigeishi H; Higashikawa K; Shimasue H; Nishi H; Oiwa H; Shindo H; Takechi M; Ohge H; Kamata N
    J Oral Maxillofac Surg; 2012 Mar; 70(3):626-31. PubMed ID: 21816533
    [No Abstract]   [Full Text] [Related]  

  • 8. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC; Lu HT; Dusetzina SB; Wu CH
    J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse sclerosing osteomyelitis of the mandible successfully treated with pamidronate: a long-term follow-up report.
    Urade M; Noguchi K; Takaoka K; Moridera K; Kishimoto H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):e9-12. PubMed ID: 22771405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
    Ito K; Blinder VS; Elkin EB
    J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.
    Famili P; Quigley S; Mosher T
    Compend Contin Educ Dent; 2011; 32(6):E106-9. PubMed ID: 23738968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of regional migratory osteoporosis.
    Spierings J; Bours S; Peeters HRM
    Osteoporos Int; 2018 Feb; 29(2):507-510. PubMed ID: 29064043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral health status of patients on oral bisphosphonates for osteoporosis.
    Kunchur R; Goss AN
    Aust Dent J; 2008 Dec; 53(4):354-7; quiz 366. PubMed ID: 19133952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis.
    Morris GJ; Mitchell EP
    J Natl Med Assoc; 2007 Jan; 99(1):35-45. PubMed ID: 17304967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of zoledronic acid for osteoporosis:evidence from studies abroad.].
    Inoue D
    Clin Calcium; 2017; 27(2):247-255. PubMed ID: 28123127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis.
    Zahrowski JJ
    Am J Orthod Dentofacial Orthop; 2009 Mar; 135(3):361-74. PubMed ID: 19268836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile osteoporosis with calvarial doughnuts: Progressive high-turnover bone loss responsive to bisphosphonate therapy.
    Couture G; Degboe Y; Baujat G; Cormier-Daire V; Laroche M
    Joint Bone Spine; 2020 May; 87(3):271-272. PubMed ID: 31678657
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.
    Yamaguchi K; Oizumi T; Funayama H; Kawamura H; Sugawara S; Endo Y
    J Oral Maxillofac Surg; 2010 Apr; 68(4):889-97. PubMed ID: 20056305
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.
    Merigo E; Manfredi M; Meleti M; Guidotti R; Ripasarti A; Zanzucchi E; D'Aleo P; Corradi D; Corcione L; Sesenna E; Ferrari S; Poli T; Bonaninil M; Vescovi P
    Acta Biomed; 2006 Aug; 77(2):109-17. PubMed ID: 17172192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.